A microfluidic CRISPR-based platform enables multiplexed and high-throughput identification of a wide range of respiratory viruses, including the ability to identify specific SARS-CoV-2 variants such as Delta and Omicron.
- Nicole L. Welch
- Meilin Zhu
- Cameron Myhrvold
